McAfee, which launched as an independent company 30 years ago, was acquired by Intel in 2010.
The new launch of McAfee marks the closing of an investment by Intel and private equity firm TPG, who valued McAfee at $4.2 billion. Another private equity firm, Thoma Bravo, joined as a minority investor.
Intel is retaining a 49 percent equity stake in the new company. Christopher Young, former general manager at Intel Security, was named CEO of McAfee. TPG Partner Bryan Taylor was appointed chairman of the board.
“We offer Chris Young and the McAfee team our full support as they establish themselves as one of the largest pure-play cybersecurity companies in the industry,” said Intel CEO Brian Krzanich, adding Intel plans to continue to collaborate with McAfee. “Security remains important to Intel.”
More articles on health IT:
Startup Insider: Solera Health
2 types of hospitals with the highest risk of data breaches
Auxilio names Cook Children’s CIO to board of directors
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
